Pages that link to "Q37183108"
Jump to navigation
Jump to search
The following pages link to Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10. (Q37183108):
Displaying 50 items.
- Few and far between: how HIV may be evading antibody avidity (Q21090507) (← links)
- Increasing the potency and breadth of an HIV antibody by using structure-based rational design (Q24631510) (← links)
- Advances in structure-based vaccine design (Q26824545) (← links)
- Structural insights on the role of antibodies in HIV-1 vaccine and therapy (Q26829461) (← links)
- Antibodies in HIV-1 vaccine development and therapy (Q27011574) (← links)
- Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity (Q27654848) (← links)
- Interactions between Lipids and Human Anti-HIV Antibody 4E10 Can Be Reduced without Ablating Neutralizing Activity (Q27658138) (← links)
- Crystal Structure of PG16 and Chimeric Dissection with Somatically Related PG9: Structure-Function Analysis of Two Quaternary-Specific Antibodies That Effectively Neutralize HIV-1 (Q27662167) (← links)
- Computational design of epitope-scaffolds allows induction of antibodies specific for a poorly immunogenic HIV vaccine epitope (Q27664365) (← links)
- Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity (Q27673861) (← links)
- A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield (Q27675032) (← links)
- A gp41 MPER-specific Llama VHH Requires a Hydrophobic CDR3 for Neutralization but not for Antigen Recognition (Q27676864) (← links)
- Structural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibody (Q27677011) (← links)
- Bispecific T-cell engagers for cancer immunotherapy (Q27693313) (← links)
- Recent Progress toward Engineering HIV-1-Specific Neutralizing Monoclonal Antibodies (Q28068946) (← links)
- Global shape and ligand binding efficiency of the HIV-1-neutralizing antibodies differ from those of antibodies that cannot neutralize HIV-1 (Q28250040) (← links)
- Virus neutralisation: new insights from kinetic neutralisation curves (Q28487427) (← links)
- Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules (Q28741431) (← links)
- Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccination. (Q30363826) (← links)
- Estimating the probability of polyreactive antibodies 4E10 and 2F5 disabling a gp41 trimer after T cell-HIV adhesion (Q31151010) (← links)
- Evaluation of CD4-CD4i antibody architectures yields potent, broadly cross-reactive anti-human immunodeficiency virus reagents (Q33558696) (← links)
- Impact of Antigen Density on the Binding Mechanism of IgG Antibodies (Q33812798) (← links)
- Antibody to gp41 MPER alters functional properties of HIV-1 Env without complete neutralization (Q33946158) (← links)
- A dimeric form of the HIV-1 antibody 2G12 elicits potent antibody-dependent cellular cytotoxicity (Q33969383) (← links)
- Eliciting neutralizing antibodies with gp120 outer domain constructs based on M-group consensus sequence (Q34016706) (← links)
- Anti-gp120 minibody gene transfer to female genital epithelial cells protects against HIV-1 virus challenge in vitro (Q34059643) (← links)
- The Antibody Germline/Maturation Hypothesis, Elicitation of Broadly Neutralizing Antibodies Against HIV-1 and Cord Blood IgM Repertoires (Q34101087) (← links)
- Characterization of neutralizing affinity-matured human respiratory syncytial virus F binding antibodies in the sub-picomolar affinity range (Q34191108) (← links)
- Design and characterization of structured protein linkers with differing flexibilities (Q34313196) (← links)
- The stem of vesicular stomatitis virus G can be replaced with the HIV-1 Env membrane-proximal external region without loss of G function or membrane-proximal external region antigenic properties. (Q34399656) (← links)
- Potent Strategy To Inhibit HIV-1 by Binding both gp120 and gp41 (Q34483474) (← links)
- Use of mutated self-cleaving 2A peptides as a molecular rheostat to direct simultaneous formation of membrane and secreted anti-HIV immunoglobulins (Q34500307) (← links)
- Anti-tat Hutat2:Fc mediated protection against tat-induced neurotoxicity and HIV-1 replication in human monocyte-derived macrophages (Q34632979) (← links)
- Antibody-mediated neutralization of flaviviruses: a reductionist view (Q34999617) (← links)
- Intra-spike crosslinking overcomes antibody evasion by HIV-1 (Q35462906) (← links)
- Rational design of vaccines to elicit broadly neutralizing antibodies to HIV-1. (Q35603504) (← links)
- Antibody mechanics on a membrane-bound HIV segment essential for GP41-targeted viral neutralization (Q35660279) (← links)
- Binding of anti-membrane-proximal gp41 monoclonal antibodies to CD4-liganded and -unliganded human immunodeficiency virus type 1 and simian immunodeficiency virus virions (Q35689608) (← links)
- Enhanced HIV-1 neutralization by antibody heteroligation (Q35735385) (← links)
- Kinetics in signal transduction pathways involving promiscuous oligomerizing receptors can be determined by receptor specificity: apoptosis induction by TRAIL. (Q35863285) (← links)
- Monoclonal antibody-based candidate therapeutics against HIV type 1. (Q35904501) (← links)
- Simulation and Theory of Antibody Binding to Crowded Antigen-Covered Surfaces (Q35953946) (← links)
- Antibody-dependent cellular cytotoxicity against primary HIV-infected CD4+ T cells is directly associated with the magnitude of surface IgG binding (Q36172128) (← links)
- Neutralizing antibody escape during HIV-1 mother-to-child transmission involves conformational masking of distal epitopes in envelope (Q36246315) (← links)
- Structural and Thermodynamic Basis of Epitope Binding by Neutralizing and Nonneutralizing Forms of the Anti-HIV-1 Antibody 4E10. (Q36281210) (← links)
- Bispecific Antibodies Targeting Different Epitopes on the HIV-1 Envelope Exhibit Broad and Potent Neutralization. (Q36334359) (← links)
- Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation (Q36977531) (← links)
- An engineered mutant of HIV-1 gp120 formulated with adjuvant Quil A promotes elicitation of antibody responses overlapping the CD4-binding site (Q37069430) (← links)
- The role of Fc receptors in HIV prevention and therapy (Q37113972) (← links)
- Bispecific Anti-HIV-1 Antibodies with Enhanced Breadth and Potency (Q37145901) (← links)